+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CINEVISTA

Cinevista Share Price

 

 

Cinevista live price: ₹15.46. It opened at ₹15 vs previous close ₹15; intraday high/low: ₹15/₹15. The 50 & 200 DMA stand at ₹15.51/₹16.03.

Cinevista Performance

  • Today's Low
  • ₹15
  • Today's High
  • ₹15
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹23
  • Open Price₹15
  • Previous Close₹15
  • Volume8,840
  • 50 DMA₹15.51
  • 100 DMA₹15.63
  • 200 DMA₹16.03

Cinevista Chart

Investment Returns

  • Over 1 Month -1.9%
  • Over 3 Month + 1.24%
  • Over 6 Month + 4.53%
  • Over 1 Year -21.4%

Smart Investing Starts Here Start SIP with Cinevista for Steady Growth!

Invest Now

Cinevista Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.6
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 89
  • P/B Ratio
  • 1.6
  • Average True Range
  • 0.77
  • EPS
  • 1.06
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.03
  • RSI
  • 49.28
  • MFI
  • 33.54

Latest Stock News Updates

K Raheja Corp, Cinevista to develop luxury homes project on 3.91 acres near Kurla

The value of the development agreement is Rs 272 crore for K Raheja Corp and Rs 78.35 crore for Cinevista.

Cinevista Consolidated March 2022 Net Sales at Rs 1.02 crore, up 102.99% Y-o-Y

NULL

7 stocks hit 52-week highs on NSE

Among the stocks that touched their 52-week highs were Cinevista, Grand Foundry and GMM Pfaudler.

Cinevista Financials

Cinevista Technicals

EMA & SMA

Current Price
₹15.46
+ 0.26 (1.71%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹15.50
  • 50 Day
  • ₹15.50
  • 100 Day
  • ₹15.60
  • 200 Day
  • ₹16.00

Resistance and Support

15.35 Pivot Speed
  • R3 15.98
  • R2 15.73
  • R1 15.60
  • S1 15.22
  • S2 14.97
  • S3 14.84

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Cinevistaas has an operating revenue of Rs. 23.97 Cr. on a trailing 12-month basis. An annual revenue growth of 106% is outstanding, Pre-tax margin of 33% is great, ROE of -22% is poor and needs improvement. NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 70 indicates it belongs to a poor industry group of Leisure-Movies & Related and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Cinevista Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-06 Audited Results
2026-03-31 Others Inter-alia, to consider 1. Re-appointment Shri. Prem Krishen Malhotra as the Whole-Time Director. 2. Re-appointment Shri. Sunil Mehta as the Managing Director. 3. Other business matters.
2026-01-29 Quarterly Results
2025-11-05 Quarterly Results
2025-08-01 Quarterly Results

Cinevista Shareholding Pattern

67.49%
30.28%
2.23%

Cinevista FAQs

Cinevista share price is ₹15 As on 20 June, 2026 | 09:43

The Market Cap of Cinevista is ₹88.8 Cr As on 20 June, 2026 | 09:43

The P/E ratio of Cinevista is 14.6 As on 20 June, 2026 | 09:43

The PB ratio of Cinevista is 1.6 As on 20 June, 2026 | 09:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23